Default company panoramic image
Logo

Leviticus Cardio

Leviticus Cardio has developed wireless power transfer system capable of providing the day-to-day power needs of available VAD implants

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Givat Shmuel, IL
  • Currency USD
  • Founded February 2008
  • Employees 5
  • Website leviticus-cardio.com

Company Summary

Most critical Heart Failure patients (30,000 to 60,000 in US) are candidates for heart transplantation or alternatively to Ventricular Assist Device (VAD), an implanted mechanical circulatory pump. VAD is connected to an external power pack by a drive line. Infection related to the drive line represents the single most important challenge to extended VAD use. Leviticus’s wireless system is robust, simple to implant, and efficient.

Team

  • Default avatar
    Michael Zilbershlag
    CEO & Co-Founder

    Former CEO and founder, Genesis-OS, developer of DRM solutions for embedded systems; previous positions: ECI Telecom (Nasdaq: ECIL), Orckit Communications (Nasdaq: ORCT), Broadlight Inc.; MBA, B.Sc.EE

  • Default avatar
    Moshe Levy
    COO & Co-Founder

    Former VP engineering, Broadlight Inc., developer of ASICs, electro-optical modules, and software for PON networks; previous positions: NetReality and RAD Data Communications; B.Sc.EE

  • Default avatar
    Yigal Kassif
    CMO & Co-Founder, M.D.

    Attending cardiac surgeon and former chief of Cardiac Surgery Intensive Care Unit, Sheba Medical Center; board certified, cardiothoracic surgery (1995); research fellowship, Cedars-Sinai Medical Center, New York; clinical fellowship: cardiac surgery, heart transplantation, and assist devices, UCLA, California

  • Default avatar
    Anton Plotkin
    Ph.D., Director of Power Transfer Division

    Department of Neuroscience, Weizmann Institute of Science; performed R&D projects for Israel Aerospace Industries in the fields of power magnetics, magnetic field generation and measurement, and mixed-signal circuits

  • Default avatar
    Stephan Schueler
    M.D., Ph.D., FRCS, Clinical Advisory Board

    Consultant cardiothoracic surgeon, Newcastle Upon Tyne Hospitals Trust, UK; professor, cardiac surgery, Medical Faculty, Carl Gustav Carus University Hospital, Dresden, Germany; past president, International Society for Heart and Lung Transplantation; past president, European Society for Cardiovascular Surgery; examiner, European Board for Thoracic and Cardiovascular Surgery

  • Default avatar
    William Edelman
    Chairman

    Medical device industry executive for over 33 years; former president and CEO, TYRX, Inc., bringing $33 million in equity financing and $7 million in strategic partner payments; held executive positions at St. Jude Medical, Pfizer, and Baxter

  • Default avatar
    Leonard A. R. Golding
    M.D. , FRACS, Clinical Advisory Board

    Staff physician, Dept. of Thoracic and Cardiovascular Surgery, Dept. of Biomedical Engineering, Cleveland Clinic; former project director, CorAide VAD; past president, International Society Rotary Blood Pumps

Previous Investors

  • Default avatar
    Trendlines Group
    Unconfirmed
    Default avatar
    The Maryland/Israel Trendlines Fund
    Unconfirmed